Once herpes simplex infects a person, the virus goes into hiding inside nerve cells, hibernating there for life, periodically waking up from its sleep to reignite infection, causing cold sores or genital lesions to recur.
Mar 15, 2018
0
81
A new study has shown how the body's immune system responds to the new shingles vaccine, Shingrix, making it more than 90% effective at protecting against the virus.
Mar 7, 2018
0
25
For previously healthy children, brain infections are rare. But about one out of every 10,000 people who are exposed to common viruses like herpes simplex or influenza will develop a potentially deadly disease, encephalitis.
Feb 22, 2018
0
0
New research in Pediatric Dermatology reports several cases of shingles that developed at the original vaccination site in healthy children after they were immunized against chicken pox. Most of these cases were initially ...
Feb 9, 2018
0
298
(HealthDay)—The prevalence of herpes simplex virus type 1 (HSV-1) and HSV-2 is 47.8 and 11.9 percent, respectively, for individuals aged 14 to 49 years, according to a February data brief published by the U.S. Centers for ...
Feb 7, 2018
0
1
(HealthDay)— Herpes infection rates are dropping among young Americans, and safer sex practices may be one reason why.
Feb 7, 2018
0
10
The Advisory Committee on Immunization Practices (ACIP) released its 2018 Recommended Immunization Schedule for adults with changes to the administration of the herpes zoster and measles, mumps, and rubella (MMR) vaccines. ...
Feb 5, 2018
0
5
Neuron-like cells created from a readily available cell line have allowed researchers to investigate how the human brain makes a metabolic building block essential for the survival of all living organisms. A team led by researchers ...
Jan 22, 2018
0
60
A team led by scientists at Northwestern Medicine has discovered a new epithelial receptor for Epstein-Barr virus, according to a study published recently in Nature Microbiology.
Jan 11, 2018
0
13
(HealthDay)—The new adjuvanted herpes zoster subunit vaccine (HZ/su) is cost-effective compared with the currently recommended live attenuated herpes zoster vaccine (ZVL), according to a study published online Jan. 2 in ...
Jan 8, 2018
0
2
